StockWatch
·
Other Textile Products
Quarterly Result22 Oct 2026, 05:10 pm

Varvee Global Q2 FY27: PAT -33% YoY to ₹6.79 Cr, revenue -30% on other-income boost

AI Summary

Varvee Global Limited (formerly Aarvee Denims & Exports Ltd) reported consolidated Q2 FY27 (quarter ended September 30, 2026) revenue from operations of ₹19.61 Cr, down 29.6% year-on-year from ₹27.83 Cr in Q2 FY26, and net profit of ₹6.79 Cr, down 33.5% YoY from ₹10.21 Cr. Sequentially the print looks far stronger — revenue rose 137% QoQ and the company swung from a ₹6.56 Cr net loss in Q1 FY27 to profit — but per the YoY-primary read, both the top line and bottom line are materially smaller than a year ago, and the composition of profit has shifted. Net profit margin (PAT/total income) compressed to 24.5% from 29.8% a year ago, and operating margin (EBITDA excluding other income, over revenue from operations) fell sharply to roughly 14.5% from 49.8% in Q2 FY26. The gap is explained by income mix: other income jumped to ₹8.07 Cr — 29% of total income — from ₹6.49 Cr a year ago, with management's own notes attributing part of this to gains on sale of property/plant (Note 5 records ₹2.02 Cr reduced from the company's held-for-sale asset block this quarter) and to temporary rent income from an MOU for additional factory use whose signed copy is still pending (Note 11). Strip out other income and core operating profit — revenue from operations (₹19.61 Cr) less total expenses (₹17.37 Cr) — was just ₹2.24 Cr for the quarter, meaning most of the reported ₹10.30 Cr pre-tax profit came from non-core items rather than the textile/trading business itself. There is no management guidance or prior concall commentary on record to grade this print against, and as a sub-₹100 Cr-revenue micro-cap mid-pivot, Varvee Global carries no visible street coverage — a web search for Q2 FY27 previews turned up none, so vsStreet is unknown rather than a miss or beat. The filing itself carries no press release or outlook commentary beyond the results. Alongside the result, the October 22 board meeting follows two equity-share-split approvals from September 25 (5:2 and 1:5) and continues the rebrand from Aarvee Denims & Exports to Varvee Global, consistent with the 2025-26 pivot away from denim manufacturing toward job-work, trading, leasing and digital-marketing revenue (notes confirm no finished-goods production this quarter). Consolidated figures equal standalone because the new subsidiary, Varvee Energy Private Limited (incorporated July 7, 2026), remains dormant with no funds infused yet. Going forward, the quarter's core run-rate — not the other-income-boosted total — is the number to watch: ₹2.24 Cr of operating profit on ₹19.61 Cr of revenue is a thin underlying margin for a company that posted a ~50% EBITDA margin on larger revenue a year ago. Whether the temporary rent arrangement converts into a recurring income stream, and whether the remaining ₹12.40 Cr held-for-sale asset block continues to generate disposal gains, will determine whether other income stays the primary profit driver into Q3 FY27.

Key Highlights

  • Revenue from operations fell 29.6% YoY to ₹19.61 Cr (Q2 FY26: ₹27.83 Cr), though up 137% QoQ from Q1 FY27's ₹8.26 Cr.
  • Net profit ₹6.79 Cr, down 33.5% YoY (Q2 FY26: ₹10.21 Cr) but a turnaround from Q1 FY27's ₹6.56 Cr loss.
  • Other income rose to ₹8.07 Cr (29% of total income) from ₹6.49 Cr a year ago, driven by asset-sale gains (Note 5: ₹2.02 Cr reduced from the held-for-sale block) and temporary rent income (Note 11) — core operating profit (revenue less expenses) was just ₹2.24 Cr.
  • NPM compressed to 24.5% from 29.8% YoY; operating margin (EBITDA ex-other income) fell to ~14.5% from ~49.8% a year ago.
  • Basic & diluted EPS ₹1.32 vs ₹1.98 a year ago and vs -₹1.27 loss per share in Q1 FY27.
  • Board approved two equity-share splits (5:2 and 1:5) on September 25, 2026, alongside the October 22 results filing.
  • New subsidiary Varvee Energy Pvt Ltd (incorporated July 7, 2026) remains dormant — NIL revenue/assets — so consolidated figures equal standalone.